Table 1 Patient and tumor characteristics.
From: Mismatch repair and treatment resistance in ovarian cancer
Patient and tumor characteristics | No. of patients |
|---|---|
FIGO stage | Â |
   Early (I-IIA) | 20 |
   Advanced (IIB-IV) | 45 |
   Unknown | 10 |
Histological type | Â |
   Serous adenocarcinoma | 36 |
   Endometrioid adenocarcinoma | 13 |
   Mucinous adenocarcinoma | 10 |
   Clear cell adenocarcinoma | 3 |
   Mixed Mullerian Tumor | 8 |
   Poorly differentiated | 3 |
   Unknown | 2 |
Tumor grade | Â |
   1 | 12 |
   2 | 29 |
   3 | 27 |
   Unknown | 7 |
Residual disease | Â |
   None | 25 |
   ≤ 1 cm | 15 |
   > 1 cm | 22 |
   Unknown | 13 |
Chemotherapy | Â |
   Cisplatin & endoxan | 45 * |
   Carboplatin & endoxan | 1 * |
   Other, not platinum containing | 5 |
   No chemotherapy | 11 |
   Unknown | 12 |
   * Response to platinum-based chemotherapy |  |
No response | 11 |
Response | 34 |
Unknown | 1 |
Total | 75 |